Skip to main content
Premium Trial:

Request an Annual Quote

Sygnis Inks Belgian Distribution Agreement with Sopachem for TruePrime

NEW YORK (GenomeWeb) – Sygnis today announced a non-exclusive distribution agreement with Sopachem for the commercialization of TruePrime products.

Under the terms of the agreement, Sopachem will promote, market, sell, and support TruePrime products for primer-free whole genome amplification in Belgium.

TruePrime products use Sygnis' multiple displacement amplification technology based on DNA primase TthPrimPol and Phi29 polymerase.

Belgium-based Sopachem is a specialized distributor with a focus on life sciences, diagnostics, and biobanking. The firm also has operations in the Netherlands and Luxembourg.

Since the beginning of the year, Sygnis has signed international distribution partnerships in Spain, Canada, Japan, and France.